Search

Kirsty Ward from the Scottish National Audit Programme highlights how good data is helping to drive improvements in standards of clinical care for hip fracture patients.

This release by Public Health Scotland (PHS) reports on systemic anti-cancer therapy (SACT) activity across NHS services in Scotland. Treatment activity includes the weekly number of appointments and the monthly and annual number of appointments and patients receiving treatment.

About this release This weekly release by Public Health Scotland presents epidemiological information on respiratory infection activity, including COVID-19, across Scotland. Due to...

The Scottish Arthroplasty Project (SAP) aims to encourage continual improvement in the quality of care provided to joint replacement surgery (arthroplasty) patients. This is currently achieved through the auditing of routinely collected SMR01 national data in Scotland.

A&E activity: week ending 12 July 2026...

Sarra Naylor, Information Manager & National Drug-related Death Data Coordinator at Public Health Scotland (PHS), outlines how a new data-processing system, Databelt, is transforming the way suspected drug-related deaths (sDRDs) are identified, shared and used to support national and local responses. It explains why this development matters, how the system works, and what it means for improving prevention, service coordination and support for those affected by drug harms.

You have a medium abdominal aortic aneurysm...

Public Health Scotland (PHS) publishes waiting times statistics across a wide range of healthcare services in Scotland. One of the most frequently asked questions we’re asked is:...

In our latest blog, Rishma Maini, Consultant in Public Health and Co-lead of Clinical Health Intelligence and Research Division at PHS, reflects on her recent attendance at the Scottish Prevention Hub’s conference in Edinburgh, which brought researchers, policy makers and community leaders together to discuss how we turn evidence into practice.

Public Health Scotland (PHS), in collaboration with the Universities of Glasgow, Strathclyde, Edinburgh and Oxford, have published a groundbreaking study in The Lancet Infectious Diseases, showing that infants under three months of age, whose mothers received the RSV vaccination during pregnancy, had around 80% reduced risk of hospitalisation due to an RSV infection compared to infants whose mothers were unvaccinated.